Core Viewpoint - Chengyi Pharmaceutical (603811.SH) reported a decline in institutional ownership in its Q3 2025 report, indicating a potential shift in investor sentiment [1] Institutional Ownership - As of October 27, 2025, three institutional investors hold a total of 17.8785 million shares of Chengyi Pharmaceutical, representing 5.46% of the total share capital [1] - The institutional ownership decreased by 2.33 percentage points compared to the previous quarter [1] Public Fund Holdings - In this period, 82 public funds were not disclosed compared to the previous quarter, including notable funds such as China Merchants Quantitative Selected Stock A and Penghua Healthcare Stock [1] Social Security Fund - One social security fund, the National Social Security Fund 604 Portfolio, reduced its holdings by 2.59% compared to the previous quarter [1]
机构风向标 | 诚意药业(603811)2025年三季度已披露前十大机构持股比例合计下跌2.33个百分点